Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
QuintilesIMS
Farmers Insurance
US Army
AstraZeneca
Boehringer Ingelheim
Queensland Health
Federal Trade Commission
Chubb

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,502,077

« Back to Dashboard

Summary for Patent: 5,502,077
Title: Fatty acid composition
Abstract:Fatty acid composition comprising at least 80% by weight of omega-3-fatty acids, salts or derivatives thereof, wherein (all-Z)-5,8,11,14,17-eicosapentaenoic acid (EPA) and (all-Z)-4,7,10,13,16,19-docosahexaenoic acid comprises at least 75% by weight of the total fatty acids. The compositions can be used for the treatment or prophylaxis of multiple risk factors for cardiovascular diseases.
Inventor(s): Breivik; Harald (Skjelsvik, NO), Borretzen; Bernt (Porsgrunn, NO), Dahl; Knut H. (Ulefoss, NO), Krokan; Hans E. (Sjetnemarka, NO), Bonaa; Kaare H. (Tromso, NO)
Assignee: Norsk Hydro A.S. (Oslo, NO)
Application Number:07/902,500
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,502,077
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 5,502,077

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,502,077

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8819110Aug 11, 1988

International Family Members for US Patent 5,502,077

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 398779 ➤ Try a Free Trial
Austria A191889 ➤ Try a Free Trial
Australia 3896789 ➤ Try a Free Trial
Australia 616784 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Covington
Deloitte
Medtronic
Julphar
US Department of Justice
Chinese Patent Office
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.